Skip to main content
OpenTrials

Clinical trial condition

Resectable Hepatocellular Carcinoma With High Risk of Recurrence

Explore clinical trials studying Resectable Hepatocellular Carcinoma With High Risk of Recurrence. Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Resectable Hepatocellular Carcinoma With High Risk of Recurrence trial results

Recruiting

Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

NCT07239245

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Cancer Hospital Chinese Academy of Medical Science Beijing, Beijing Municipality, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The First Hospital of China Medical University Shenyang, Liaoning, China
  • Shanxi Cancer Hospital Taiyuan, Shanxi, China
View Trial Details

Related conditions